parenchyma in tumours is formed of the malignant cells, while stroma is the non-malignant supporting cells that are essential for growth
cancers can be associated with inflammation e.g., barretts metaplasia and h.pylori leading to cancer
seed and soil hypothesis:
certain cancers metastasise to particular organs due to favourable reactions between tumour cells and organ microenvironment
secreted factors from the primary tumour may also influence the target organ
interstitial fluid pressure is higher in tumours due to vascular abnormalities and defects in the lymph system
reduces drug concentrations in tumours
high MMPs often correlate with a more invasive phenotype
cancer associated fibroblasts produce factors that promote angiogenesis and attract pro-inflammatory cells like macrophages (stimulate cancer cell invasion)
infiltrate excluded tumours = immune cells trapped at tumour:stroma surface
respond poorly to immunotherapies
infiltrated-inflamed tumours = hot tumours, adaptive anti-tumour mechanisms may be overcome
can potentially elimiate tumour
infiltrated-tertiary lymphoid structures = lymphoid structures present at invasive margin of tumour may suggest ongoing immune priming
better prognosis
tumour associated macrophages are M2 like
immunosuppressive
promote treg formation
poorer prognosis
angiogenesis promotion
promote metastasis
myeloid derived suppressor cells
induce by inflammation
inhibit NK and DC function
induce tregs
deplete arginase - interfering with t cell function
natural killer cells
tumour cells downregulate MHC, so should be targets of NKs
intratumoural NKs are often anergic so can't kill targets
caused by TF=GF-beta released from tumour cells
high levels of CD8+ or TH1 t cells increase prognosis
cd4+ TH1 cells can activate macrophages and kill tumour cells
cd4+ TH2 t cells are thought to be a poor prognostic indicator
tregs correlate with poorer prognosis
hypoxia can increase CCL22, and tumour produce this
attracts tregs
tregs express CD25, so starve effector T cells of IL2
low levels of arginine leads to decreased t cell receptor signalling in t cells